A Double Blind Placebo Controlled Study of Valacyclovir in Cognitive Impairment and Mood Symptoms of Bipolar Disorder.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Valaciclovir (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Pharmacodynamics
- 18 May 2012 Planned end date changed from 1 Oct 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 18 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Jan 2011 Planned end date changed from 1 Jul 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.